UnitedHealth Could Get Worse Before It Gets Better
After a punishing first half of the year, UnitedHealth’s latest earnings report delivered another gut punch.
The stock, which had already been cut in half year-to-date by July 31, slid even further following the release.
Between deteriorating fundamentals, mounting regulatory pressure, and a brutal earnings revision, it’s fair to ask whether UnitedHealth finally hit bottom,
» Read more about: UnitedHealth Could Get Worse Before It Gets Better »
Read More
Why 1 Insider Just Bet Big on Palantir Near Its All-Time High
In a world flooded with hype about artificial intelligence, few companies have the real-world track record to back it up but Palantir Technologies certainly does. Yet skeptics keep pointing to valuation as overhyped so why is one insider still buying?
Key Points
-
Palantir’s 20-year lead in data analytics puts it in a good spot to dominate enterprise AI.
» Read more about: Why 1 Insider Just Bet Big on Palantir Near Its All-Time High »
Read More
Datadog Stock Looks Undervalued
From retailers to healthcare providers, companies are now building digital backbones that need to run non-stop 24/7, 365 days a year. But keeping those systems humming without hiccups? That’s where Datadog steps in.
Datadog (NASDAQ: DDOG) makes cloud infrastructure monitoring software that acts like a digital nervous system for enterprises. If something breaks,
» Read more about: Datadog Stock Looks Undervalued »
Read More
Uber’s $1 Trillion Moonshot
Uber isn’t just about getting you from point A to point B anymore. It’s stealthily becoming one of the most powerful tech platforms of the next decade, and the lynchpin in that transformation is autonomy.
While most investors still think of Uber as a ride-hailing and food delivery app, under the hood, the company is evolving fast.
» Read more about: Uber’s $1 Trillion Moonshot »
Read More
AMD’s AI Advantage May Just Be Getting Started
While the spotlight often shines brightest on Nvidia, another chipmaker has been clawing its way into the conversation and could soon be in a position to steal the show.
That company is Advanced Micro Devices (NASDAQ: AMD), and it’s gearing up to report second-quarter earnings early next month.
With the stock already up 34% this year,
» Read more about: AMD’s AI Advantage May Just Be Getting Started »
Read MoreThe Ivy
1 Science Powerhouse To Own for the Next Decade
Thermo Fisher Scientific has a knack for thriving even in challenging markets. While the company isn’t entirely immune to today’s global headwinds, slower biopharmaceutical spending, tighter budgets in academic labs, and muted demand in China, it has weathered the storm far better than most of its peers.
The reason?
A combination of unmatched scale,
» Read more about: 1 Science Powerhouse To Own for the Next Decade »
Read MoreThe Spotlight
Can You Really Earn a 100% Yield From This Tesla-Based ETF?
A wave of funds has popped up promising double-digit income yields, many of them built on familiar covered call tactics. But one issuer, YieldMax, has taken the concept to an entirely different level. Think 30%, 50%, even 100%-plus yields.
The poster child is the YieldMax Tesla Option Income Strategy ETF, ticker TSLY. This fund aims to milk income from Tesla (NASDAQ: TSLA) by trading options,
» Read more about: Can You Really Earn a 100% Yield From This Tesla-Based ETF? »
Read MoreThe Daily
Eos Energy (EOSE) Hits Fresh High as New Software to Support Growing Energy Demand from AI
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!
AI is eating the world—and the machines behind it are ravenous.
Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy.